CIK 0001101026 · Non-accelerated filer<br>Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870699977
- Phone
- (248) 452 9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-22 | Maggiore Christopher D. Director | Purchase | +31,336 | $8.34 | $261K | 498,443 |
| 2024-08-22 | Maggiore Christopher D. Director | Purchase · Common Stock Purchase Warrants | +3,133 | $8.34 | $26K | 3,133 |
| 2024-07-26 | Maggiore Christopher D. Director | Purchase | +2,080 | $8.05 | $17K | 467,107 |
| 2024-07-26 | Maggiore Christopher D. Director | Purchase · Common Stock Purchase Warrant | +208 | $8.05 | $2K | 208 |
| 2024-06-12 | Maggiore Christopher D. Director | Purchase | +3,764 | $7.97 | $30K | 465,027 |
| 2024-06-11 | Cornell Alison A Director | Grant or award | +6,273 | 245,985 | ||
| 2024-06-11 | Maggiore Christopher D. Director | Grant or award | +6,273 | 461,263 | ||
| 2024-06-11 | Masterson Nola E Director | Grant or award | +6,273 | 122,024 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Grant or award | +36,630 | 373,446 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Grant or award | +81,544 | $7.96 | $649K | 454,990 |
| 2024-06-05 | Maggiore Christopher D. Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −1,902 | 0 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −7,000 | 0 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −2,632 | 0 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −707 | 0 | ||
| 2024-06-05 | Maggiore Christopher D. Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −3,626 | 0 | ||
| 2024-06-05 | Masterson Nola E Director | Grant or award | +30,010 | 30,876 | ||
| 2024-06-05 | Masterson Nola E Director | Grant or award | +84,941 | $7.96 | $676K | 115,817 |
| 2024-06-05 | Masterson Nola E Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −1,902 | 0 | ||
| 2024-06-05 | Masterson Nola E Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −4,333 | 0 | ||
| 2024-06-05 | Masterson Nola E Director | Returned to the company · Nonstatutory Stock Option to Purchase Common Stock | −2,632 | 0 |
Page 3 of 12 · 228 trades